UBS AG - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 139 filers reported holding ENDOLOGIX INC in Q4 2013. The put-call ratio across all filers is 733.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AG ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2014$32,000
-73.8%
3,000
-62.3%
0.00%
Q2 2014$122,000
+35.6%
7,967
+13.0%
0.00%
Q1 2014$90,000
-19.6%
7,049
+10.0%
0.00%
Q4 2013$112,000
-52.3%
6,411
-56.0%
0.00%
Q3 2013$235,000
+20.5%
14,569
-0.9%
0.00%
Q2 2013$195,00014,7000.00%
Other shareholders
ENDOLOGIX INC shareholders Q4 2013
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$49,653,0005.91%
Essex Woodlands Management, Inc. 1,257,468$21,220,0003.88%
PURA VIDA INVESTMENTS, LLC 205,100$2,515,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,347,113$28,776,0001.11%
First Light Asset Management, LLC 180,963$2,219,0001.10%
ArrowMark Colorado Holdings LLC 2,889,546$35,426,0000.97%
PALISADE CAPITAL MANAGEMENT, LP 2,149,949$26,358,0000.78%
Iguana Healthcare Management, LLC 150,000$1,839,0000.72%
CADIAN CAPITAL MANAGEMENT, LP 1,492,443$18,297,0000.66%
WASHINGTON CAPITAL MANAGEMENT, INC 85,882$1,053,0000.66%
View complete list of ENDOLOGIX INC shareholders